- Home
- / EastGate Biotech
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
EastGate Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-28
Market Capitalization
$9.3 M
2024-10-28
Revenue
$132 K
FY, 2015
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|
| Revenue | 132.0K | |||||
| Cost of goods sold | 19.2K | |||||
| Gross profit | 112.8K | |||||
| Gross profit margin, % | 85.5% | |||||
| General and administrative expense | 23.9K | 383.5K | 1.4M | 3.7M | 2.5M | 1.8M |
| Operating expense total | 23.9K | 488.9K | 1.6M | 4.6M | 4.3M | 2.6M |
| EBIT | (23.9K) | (605.8K) | (1.7M) | (4.8M) | (4.2M) | (2.6M) |
| EBIT margin, % | -3159.5% | |||||
| Interest expense | 6.0K | 17.0K | 64.2K | 88.9K | 109.9K | 344.0K |
| Pre tax profit | (29.9K) | (622.8K) | (1.7M) | (4.9M) | (4.3M) | (3.0M) |
| Net Income | (29.9K) | (622.8K) | (1.7M) | (4.9M) | (4.3M) | (3.0M) |